Novel bi-transition metallic encapsulated naphthalene-like Si20prismatic cage: A DFT investigation

Theoretical prediction of superatom WSi12-based catalysts for CO oxidation by N2O

Catalytic conversion of N2O and CO into nonharmful gases is of great significance to reduce their adverse impact on the environment. The potential of the WSi12 superatom to serve as a new cluster catalyst for CO oxidation by N2O is examined for the first time. It is found that WSi12 prefers to adsorb the N2O molecule rather than the CO molecule, and the charge transfer from WSi12 to N2O results in the full activation of N2O into a physically absorbed N2 molecule and an activated oxygen atom that is attached to an edge of the hexagonal prism structure of WSi12. After the release of N2, the remaining oxygen atom can oxidize one CO molecule via overcoming a rate-limiting barrier of 28.19 kcal mol-1. By replacing the central W atom with Cr and Mo, the resulting MSi12 (M = Cr and Mo) superatoms exhibit catalytic performance for CO oxidation comparable to the parent WSi12. In particular, the catalytic ability of WSi12 for CO oxidation is well maintained when it is extended into tube-like WnSi6(n+1) (n = 2, 4, and 6) clusters with energy barriers of 25.63-29.50 kcal mol-1. Moreover, all these studied MSi12 (M = Cr, Mo, and W) and WnSi6(n+1) (n = 2, 4, and 6) species have high structural stability and can absorb sunlight to drive the catalytic process. This study not only opens a new door for the atomically precise design of new silicon-based nanoscale catalysts for various chemical reactions but also provides useful atomic-scale insights into the size effect of such catalysts in heterogeneous catalysis.

On the possibility of using the Ti@Si16 superatom as a novel drug delivery carrier for different drugs: A DFT study

The potential application of an experimentally synthesized superatom Ti@Si₁₆ as a novel drug carrier for cisplatin (DDP), isoniazid (INH), acetylsalicylic acid (ASA), 5-fluorouracil (5-Fu), and favipiravir (FPV) has been explored by density functional theory. It is observed that the Pt atom of DDP can be effectively absorbed on Ti@Si₁₆ via a "donation-back donation" electron transfer mechanism, resulting in a moderate adsorption energy of -19.95 kcal/mol for DDP@[Ti@Si₁₆]. As for INH, it prefers to combine with Ti@Si₁₆ via the N atom of pyridine ring by forming a strongly polar N-Si bond. Differently, the interaction between Ti@Si₁₆ and the ASA, 5-Fu, and FPV drugs is dominated by the Van der Waals interaction. Our results reveal that DDP@[Ti@Si₁₆] possesses a moderate recovery time under body temperature, which benefits the desorption of DDP from Ti@Si₁₆. More importantly, the release of DDP drug from the Ti@Si₁₆ surface can be effectively controlled by exerting small orientation external electric fields on the DDP@[Ti@Si₁₆] complex. Therefore, this study demonstrates that Ti@Si₁₆ can serve as a promising drug carrier for DDP, and thus will further expand its practical applications in the biomedical field.